カテゴリ： MarketLine, アメリカ, 企業調査

Citibank NA：企業の戦略・SWOT・財務情報

◆英語タイトル：Citibank NA - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C6256
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：38
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Citibank NA – Strategy, SWOT and Corporate Finance Report
Summary

Citibank NA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Citibank NA (Citibank), a subsidiary of Citigroup Inc., offers retail and commercial banking; and investment services. Its retail offerings include accounts, certificate of deposits, and loans and mortgages. Commercial banking comprises cash management, credit, online banking solutions, trade finance, and global business solutions. Investment solutions include annuities, retirement savings, bonds, stocks, insurance, security-based lending, trust and estate planning, investment portfolio management, and online investment. The bank serves individual, corporate, high net worth individual and wealthy family clients. Citibank is headquartered in Sioux Falls, South Dakota, the US.

Scope

- Detailed information on Citibank NA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Citibank NA in the form of a SWOT analysis
- An in-depth view of the business model of Citibank NA including a breakdown and examination of key business segments
- Intelligence on Citibank NA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Citibank NA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Citibank NA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Citibank NA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Citibank NA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Citibank NA: Company Overview 9
Citibank NA: Overview and Key Facts 9
Citibank NA: Overview 9
Citibank NA: Key Facts 9
Citibank NA: Key Employees 10
Citibank NA: Key Employee Biographies 11
Citibank NA: Major Products and Services 12
Citibank NA: Company History 13
Citibank NA: Key Competitors 17
Citibank NA: Company Analysis 18
Citibank NA: Business Description 18
Citibank NA: SWOT Analysis 19
Citibank NA: SWOT Overview 19
Citibank NA: Strengths 19
Citibank NA: Weaknesses 20
Citibank NA: Opportunities 20
Citibank NA: Threats 21
Citibank NA: Corporate Financial Deals Activity 22
Citibank NA: Financial Deals Overview 22
Citibank NA: Top Deals 2014 – 2018YTD* 24
Citibank NA: Advisors 25
Citibank NA: Top Legal Advisors 25
Citibank NA: Top Financial Advisors 25
Citibank NA: Capital Raising 26
Citibank NA: Divestments 27
Citibank NA: Recent Developments 28
Citibank NA: News and Events Summary 28
Citibank NA: Business Expansion 31
Citibank NA: Contracts 32
Citibank NA: Corporate Governance 34
Citibank NA: Financial Performance 34
Citibank NA: Regulatory and Legal Events 34
Citibank NA: Strategy and Operations 35
Appendix 36
Contact Us 36
Methodology 36
About MarketLine 37

List of Tables
Table 1: Citibank NA: Key Facts
Table 2: Citibank NA: Key Employees
Table 3: Citibank NA: Company History
Table 4: Citibank NA: Key Competitors
Table 5: Citibank NA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Citibank NA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Citibank NA: Top Deals 2014 - 2018YTD*
Table 8: Citibank NA: Legal Advisor Ranking by Value (US$m)
Table 9: Citibank NA: Financial Advisor Ranking by Value (US$m)
Table 10: Citibank NA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 11: Citibank NA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 12: Citibank NA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 13: Citibank NA: Divestments by Geography (2014 - YTD*2018)
Table 14: Citibank NA: News and Events Summary
Table 15: Citibank NA: Business Expansion
Table 16: Citibank NA: Contracts
Table 17: Citibank NA: Corporate Governance
Table 18: Citibank NA: Financial Performance
Table 19: Citibank NA: Regulatory and Legal Events
Table 20: Citibank NA: Strategy and Operations

List of Figures
Figure 1: Citibank NA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Citibank NA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Citibank NA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 4: Citibank NA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 5: Citibank NA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Citibank NA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Citibank NA：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Garmin Ltd.：企業のM&A・事業提携・投資動向
    Garmin Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Garmin Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Emmi AG：企業のM&A・事業提携・投資動向
    Emmi AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Emmi AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • EffRx Pharmaceuticals SA：製薬・医療：M&Aディール及び事業提携情報
    Summary EffRx Pharmaceuticals SA (EffRx), formerly EffRx Inc is a pharmaceutical company that develops and commercializes prescription medications for specialty indications. The company offers therapeutics for men and women with musculoskeletal, genitourinary and endocrine disorders. It provides com …
  • Open Monoclonal Technology Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Open Monoclonal Technology Inc (OMT), a subsidiary of Ligand Pharmaceuticals Inc, is a biotechnology company that discovers and develops human monoclonal antibody platform based on transgenic rats. The company provides products such as omnirat, omnimouse and omniflic. Its omnirat is an antib …
  • Gene Techno Science Co Ltd (4584)：製薬・医療：M&Aディール及び事業提携情報
    Summary Gene Techno Science Co Ltd (GTS) is a developer and marketer of drug and antibodies for intractable diseases, cancer, and rare diseases. The company develops biological and biosimilar products. Its biological pipeline products include GND-004, for oncology; GND-001 for immunological disease …
  • Management Consulting Group Plc (MMC)：企業の財務・戦略的SWOT分析
    Summary Management Consulting Group plc (MCG), formerly Proudfoot Consulting Plc, is a professional services consultancy firm. The company through its subsidiaries designs, implements and accelerates operational transformation for the long-term benefit of a business. It provides consultancy and mana …
  • Poxel SA (POXEL)：企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Findel plc：企業の戦略・SWOT・財務分析
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Viterra Inc.：企業のM&A・事業提携・投資動向
    Viterra Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Viterra Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • National Institutes of Health：企業のM&A・事業提携・投資動向
    National Institutes of Health - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Institutes of Health Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Procter & Gamble SA Pty Ltd：企業の戦略的SWOT分析
    Procter & Gamble SA Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Isagen SA ESP：企業の発電所・SWOT分析2018
    Isagen SA ESP - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (exec …
  • Tobira Therapeutics Inc (TBRA)-医療機器分野：企業M&A・提携分析
    Summary Tobira Therapeutics Inc (Tobira), formerly Regado Biosciences, Inc, which develops and commercializes therapies for the treatment of to treat non-alcoholic steatohepatitis (NASH) and other liver diseases, inflammation, fibrosis and HIV. Its pipeline products include Cenicriviroc (CVC) and Ev …
  • Korea National Oil Corp：企業の戦略的SWOT分析
    Korea National Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Msig Holdings (Asia) Pte. Ltd.：企業の戦略・SWOT・財務分析
    Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Msig Holdings (Asia) Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bangkok Bank Public Co Ltd：企業のM&A・事業提携・投資動向
    Bangkok Bank Public Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bangkok Bank Public Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Public Service Enterprise Group Inc：発電所・企業SWOT分析
    Public Service Enterprise Group Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Proserv：石油・ガス：M&Aディール及び事業提携情報
    Summary Proserv is an energy service provider that offers engineering services. The company offers drilling, surface, subsea and decommissioning services. Its subsea services comprise subsea engineering, subsea production equipment and services, subsea components and accessories, subsea production e …
  • Sonova Holding AG：企業の戦略・SWOT・財務分析
    Sonova Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sonova Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Goals Soccer Centres plc：企業の戦略的SWOT分析
    Goals Soccer Centres plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆